tech
Insilico on Applying AI to Transform Drug Discovery
Insilico Medicine Founder & CEO Alex Zhavoronkov discusses how his company aims to apply artificial intelligence to revolutionize drug discovery and longevity research. He speaks with Haslinda Amin from the sidelines of 'JPMorgan Global China Summit' in Shanghai. (Source: Bloomberg)
Read full story on Bloomberg Tech → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Tech alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop